valsartan has been researched along with Abnormality, Heart in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 7 (77.78) | 2.80 |
| Authors | Studies |
|---|---|
| Liuzzo, G; Volpe, M | 1 |
| Colvin, BM; Guglin, M; Kido, K; Szymanski, TW | 1 |
| Abozied, O; Anderson, JH; Andi, K; Burchill, LJ; Connolly, HM; Egbe, AC; Jain, CC; Miranda, WR | 1 |
| Liu, T; Roever, L; Tse, G; Wang, Y | 1 |
| Maurer, SJ; Tutarel, O | 1 |
| Appadurai, V; Malpas, T; Nicolae, M; Thoreau, J | 1 |
| Aboulhosn, J; Lin, J; Lluri, G; Miner, P; Reardon, L; Whalen, K | 1 |
| Ewert, P; Hager, A; Maurer, SJ; Pujol Salvador, C; Schiele, S; Tutarel, O | 1 |
| Bouma, BJ; Groenink, M; Mulder, BJ; Pieper, PG; Roos-Hesselink, JW; Sieswerda, GT; van der Bom, T; van Dijk, AP; Vliegen, HW; Winter, MM; Zwinderman, AH | 1 |
1 review(s) available for valsartan and Abnormality, Heart
| Article | Year |
|---|---|
Sacubitril/Valsartan Off-Label Uses for Heart Failure.
Topics: Adult; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cardiomyopathies; Drug Combinations; Heart Defects, Congenital; Heart Failure; Humans; Neprilysin; Off-Label Use; Stroke Volume; Tetrazoles; Valsartan; Ventricular Function, Left | 2022 |
2 trial(s) available for valsartan and Abnormality, Heart
| Article | Year |
|---|---|
Clinical benefits of angiotensin receptor-Neprilysin inhibitor in adults with congenital heart disease.
Topics: Adult; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Drug Combinations; Heart Defects, Congenital; Heart Failure; Humans; Neprilysin; Retrospective Studies; Stroke Volume; Tetrazoles; Valsartan | 2023 |
Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Double-Blind Method; Exercise Tolerance; Female; Follow-Up Studies; Heart Defects, Congenital; Heart Ventricles; Humans; Magnetic Resonance Imaging; Male; Multidetector Computed Tomography; Outcome Assessment, Health Care; Pilot Projects; Quality of Life; Stroke Volume; Tetrazoles; Transposition of Great Vessels; Valine; Valsartan; Ventricular Dysfunction, Right | 2013 |
6 other study(ies) available for valsartan and Abnormality, Heart
| Article | Year |
|---|---|
VANISHing the progression of cardiac abnormalities in hypertrophic cardiomyopathy with early use of valsartan?
Topics: Cardiomyopathy, Hypertrophic; Heart Defects, Congenital; Humans; Tetrazoles; Valsartan | 2022 |
Sacubitril/valsartan in the treatment of cancer therapy-related cardiac dysfunction.
Topics: Adult; Aminobutyrates; Biphenyl Compounds; Drug Combinations; Heart Defects, Congenital; Heart Failure; Humans; Neoplasms; Tetrazoles; Valsartan | 2020 |
Expanding the indications for sacubitril/valsartan to unchartered territories.
Topics: Adult; Aminobutyrates; Biphenyl Compounds; Drug Combinations; Heart Defects, Congenital; Heart Failure; Humans; Tetrazoles; Valsartan | 2020 |
Sacubitril/Valsartan in Adult Congenital Heart Disease Patients With Chronic Heart Failure - A Single Centre Case Series and Call for an International Registry.
Topics: Adult; Aminobutyrates; Biphenyl Compounds; Chronic Disease; Drug Combinations; Female; Heart Defects, Congenital; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Registries; Tetrazoles; Valsartan | 2020 |
Early Experience With Sacubitril/Valsartan in Adult Patients With Congenital Heart Disease.
Topics: Adult; Aged; Aged, 80 and over; Aminobutyrates; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Biphenyl Compounds; Drug Combinations; Female; Follow-Up Studies; Heart Defects, Congenital; Heart Failure; Humans; Male; Middle Aged; Neprilysin; Retrospective Studies; Stroke Volume; Tetrazoles; Time Factors; Treatment Outcome; Valsartan | 2019 |
Sacubitril/valsartan for heart failure in adults with complex congenital heart disease.
Topics: Adult; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Drug Combinations; Female; Follow-Up Studies; Heart Defects, Congenital; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Retrospective Studies; Tetrazoles; Valsartan | 2020 |